OREGON CLINICAL AND TRANSLATIONAL RESEARCH INSTITUTE

俄勒冈临床与转化研究所

• 批准号: 8365044
• 负责人: ERIC S. ORWOLL
• 金额: $ 369.18万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8365044
• 关键词: Clinical Research; Oregon; Research Institute; Translational Research

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. DESCRIPTION (provided by applicant): After a successful and highly productive first grant period, the Oregon Clinical and Translational Research Institute (OCTRI) is well positioned to have greater impact in the next grant period. OCTRI's goals are: Specific Aim 1. Generate sustained OHSU and KPCHR research growth and productivity across the spectrum of translational science. Specific Aim 2. Translate new biomedical knowledge into widespread advances in human health and healthcare reform. Specific Aim 3. Create a regional consortium for clinical and translational research. Specific Aim 4. Expand the impact of the strong OCTRI educational curriculum, develop an institution-wide, coordinated career development process that builds on the strengths of existing programs, and extend it throughout the region and nationally. Specific Aim 5. Enhance key infrastructure programs to support local and regional clinical and translational research. These plans will build on major progress during the first grant period to further expand clinical and translational research, career development and benefits to human health. OCTRI will utilize a series of innovative partnerships to leverage CTSA support, expand its extensive collaborations with communities, and take advantage of a regional consortium of academic institutions working together to enhance translation. As a member of the CTSA Consortium, OCTRI will contribute unique expertise and resources to the combined effort to solve biomedical problems. Oregon Health and Science University and its partner institution Kaiser Permanente Center for Health Research have committed strong leadership support and substantial institutional commitment to OCTRI's continued mission. PUBLIC HEALTH RELEVANCE (provided by applicant): OCTRI will have a major influence on clinical and translational research at OHSU and KPCHR, and will increase their contributions to biomedical discovery. As the only academic medical center in Oregon, OHSU has a unique opportunity to catalyze translational research growth on a regional scale. Via its participation in the CTSA Consortium, OCTRI will advance national research productivity.

该子项目代表CTSA资金百分比的估计值 被用于广泛的研究领域（艾滋病研究，儿科研究或 临床试验）。 列出的总成本只是CTSA数量的估计值 基础设施朝向这一研究领域，而不是直接提供的资金 NCRR授予subproject或subproject人员。 描述（由申请人提供）：俄勒冈州临床和转化研究所（OCTRI）成功且高效的第一赠款期后，在下一个赠款期内有更大的影响力。 OCTRI的目标是：特定目标1。在翻译科学领域中产生持续的OHSU和KPCHR研究的增长和生产力。具体目标2。将新的生物医学知识转化为人类健康和医疗改革方面的广泛进步。特定目的3。创建一个用于临床和转化研究的区域联盟。具体目标4。扩大强大的OCTRI教育课程的影响，开发范围内的机构，协调的职业发展过程，以现有计划的优势为基础，并在整个地区和全国范围内扩展。具体目标5。增强关键基础设施计划，以支持本地和区域临床和转化研究。这些计划将在第一个赠款期间取得重大进展，以进一步扩大临床和转化研究，职业发展和对人类健康的益处。 OCTRI将利用一系列创新的合作伙伴关系来利用CTSA的支持，扩大与社区的广泛合作，并利用共同努力增强翻译的学术机构的区域财团。作为CTSA财团的成员，OCTRI将为解决生物医学问题的综合努力提供独特的专业知识和资源。俄勒冈州健康与科学大学及其合作伙伴机构Kaiser Permanente健康研究中心已为OCTRI的持续任务提供了强有力的领导力支持和实质性的机构承诺。 公共卫生相关性（由申请人提供）：OCTRI将对OHSU和KPCHR的临床和转化研究产生重大影响，并将增加其对生物医学发现的贡献。作为俄勒冈州唯一的学术医学中心，OHSU有一个独特的机会，可以在区域范围内催化转化研究的增长。通过参与CTSA财团，OCTRI将提高国家研究生产力。